Ep 289 - Refractory VF, Double Sequential Defibrillation, and the Future of Cardiac Arrest

Mar 20, 2026

Sheldon Cheskes, resuscitation scientist and emergency medicine professor known for DOSE VF and drone AED work. He explains refractory versus recurrent VF, how double sequential external defibrillation and vector change alter current pathways, and why timing and system protocols matter. The conversation covers trial evidence, practical steps for safe DSED rollout, and future tech like detection sensors and drone AED delivery.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Recurrent VF Can Be A Defibrillation Failure

Recurrent VF often looks like a non-defibrillation problem but can be due to inadequate defibrillation.
Sheldon Cheskes explains many recurrent VF cases re-enter VF after ROSC because AL pad vectors miss posterior inferior myocardium.

ADVICE

Escalate To DSED Early After Three Shocks

Move to DSED early rather than as a Hail Mary after many failed shocks.
The DOSE‑VF protocol escalated to DSED after shock three and showed a doubling of neurologically intact survival versus standard care.

INSIGHT

AP Pad Position Alters Current Path For Better Defibrillation

AP pad position changes the current path and delivers more current to posterior inferior ventricle than AL.
Cheskes argues AP produces a more effective current distribution which likely underlies improved defibrillation success.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

What do we really know about treating refractory ventricular fibrillation?
And why are we still waiting to use strategies that might actually work?

In this episode, we talk to Sheldon Cheskes about the evolving science of cardiac arrest, with a focus on refractory and recurrent ventricular fibrillation. We explore the evidence behind double sequential external defibrillation (DSED), how it compares to standard defibrillation, and what the DOSE VF trial has changed in practice.

This is not just about adding another shock.
It’s about understanding why defibrillation fails, how vector and energy delivery matter, and when a different approach might improve outcomes.

We also discuss:

The difference between refractory and recurrent VF — and why it matters
What DSED and vector change actually do in physiological terms
Why guidelines have been slow to move despite emerging evidence
The role of antiarrhythmics, adrenaline, and sequence of care
Practical considerations for introducing DSED into real systems
What comes next — from smarter detection to post-arrest recovery

This is a conversation grounded in real-world resuscitation.
It challenges current practice without overselling the evidence.

Key Learning Points

Refractory VF (persistent after multiple shocks) and recurrent VF (returns after ROSC) are distinct clinical problems with different implications
Double sequential external defibrillation (DSED) may improve outcomes in refractory VF by altering current pathways and myocardial depolarisation
Timing matters — waiting too long to escalate may reduce the chance of success
Current guidelines remain cautious, reflecting the balance between evidence and implementation risk
Defibrillation strategy is only one part of a complex system that includes high-quality CPR, drug therapy, and post-resuscitation care

Why This Matters

Cardiac arrest survival remains low.

Small improvements in early resuscitation can have large system-wide effects.
Understanding when standard care is failing — and what to do next — is where expertise matters.

Learning from podcasts?

If podcasts form part of your CPD, you can log your listening time across all podcasts on MedPod Learn — not just St Emlyn’s — and generate structured reflection.

The app is free to download, includes a one-month free trial, and offers globally adjusted pricing. If you are already listening, you may as well make it count.